1.11
-0.02(-1.77%)
Currency In USD
Address
1415 Ranch Road 620 South
Lakeway, TX 78734
United States of America
Phone
512 598 0931
Website
Sector
Healthcare
Industry
Biotechnology
Employees
2
First IPO Date
May 07, 2021
| Name | Title | Pay | Year Born |
| Richard Cunningham | Chief Executive Officer & Director | 461,250 | 1971 |
| Joseph F. Lawler | Founder & Chairman | 11,000 | 1972 |
| Daniel V. George | Acting Chief Financial Officer & Secretary | 208,755 | 1970 |
| Kenneth C. Cundy | Chief Scientific Officer | 512,467 | 1959 |
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.